Faculty

Institution

Unit

Venue

Sarah Harding

Assistant Professor of Pediatrics

Upstate Medical University

Sarah Harding is currently serving as a Center For Development, Behavior And Genetics Assistant Professor of Pediatrics at Upstate Medical University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Sarah Harding

Upstate Medical University

Assistant Professor of Pediatrics

You can click a keyword to filter the displayed items

rheumatology systemic scleroderma medicine scleroderma clinical rheumatology pathology pharmacology arthritis dermatological treatment rheumatism systemic sclerosis dermatology clinical research rheumatoid arthritis neuropathology autoimmune diseases canadian studies pharmacotherapy inflammatory rheumatic disease systemic treatment progressive systemic sclerosis high disease activity calcium channel blockers pathogenesis blood vessels cellular physiology circulatory physiology disease mapping treatment and prevention inflammatory diseases rheumatoid disorder vascular pharmacology disease progression vasculitis neurological disorders clinical therapeutics skin pharmacology immune dysregulation clinical immunology inflammatory markers large cohort digital ulcers c-reactive protein secondary raynaud large database best practices practice variability ssc centres phosphodiesterase 5 drug interventions generic protocol reactive protein hospital medicine medical ethics outcomes research translational research pediatric anesthesia patient safety pediatric nursing critical care clinic health care child neurology intensive care medical education clinical epidemiology pediatrics gross anatomy medical history health services research surgery obstetric anesthesia emergency medicine primary care trauma health informatics medical systems critical care pediatric pulmonology anesthesiology emergency nursing surgical education critical care nurse diagnosis disaster medicine individualized medicine clinical investigation pediatric transplantation resuscitation clinical trials anesthesia health sciences internal medicine hospital infections medical devices pediatric urology rehabilitation congenital heart surgery translational medicine intensive care nursing sepsis orthopaedic surgery

Notable Scholarly Works

Notable Federal Grants

Collaborators

Phosphodiesterase 5 Inhibitors (Pde5I) for the Treatment of Raynaud's Phenomenon. Cochrane Database of Systematic Reviews (2023)

phosphodiesterase 5rheumatologysclerodermamedicinepharmacology

Drug Interventions Versus Placebo for the Treatment of Raynaud’s Phenomenon: Generic Protocol. Cochrane Database of Systematic Reviews (2021)

drug interventionsgeneric protocolskin pharmacologyrheumatologydermatological treatmentmedicinepharmacologyclinical therapeuticspharmacotherapyclinical trials

Calcium Channel Blockers for Primary and Secondary Raynaud's Phenomenon. Cochrane Database of Systematic Reviews (2017)

circulatory physiologysecondary raynaudphysiologyblood vesselselectrophysiologycellular physiologyvascular pharmacologyneurophysiology

Sat0458 a Meta-Analysis of the Effects of Calcium Channel Blockers for the Treatment of Raynaud's Phenomenon Including Low and Higer Doses of Calcium Channel Blockers. Annals of the Rheumatic Diseases (2015)

calcium channel blockersphysiologyelectrophysiologyneuromuscular medicinephenomenon including lowhiger dosesmedicinepharmacology

Agreement With Guidelines From a Large Database for Management of Systemic Sclerosis: Results From the Canadian Scleroderma Research Group. The Journal of Rheumatology (2012)

large databasechronic diseasesrheumatologysystemic sclerosisdisease progressionclinical epidemiologysclerodermadermatological treatmentsystemic treatmentmedicineautoimmune diseasessystemic sclerodermahealth sciencesclinical rheumatology

Association of C‐Reactive Protein With High Disease Activity in Systemic Sclerosis: Results From the Canadian Scleroderma Research Group. Arthritis Care & Research (2012)

Chayawee MuangchanSarah HardingSarit KhimdasAshley BonnerMurray BaronJanet Pope

pathologyarthritissystemic sclerosisrheumatoid disorderhigh disease activityrheumatoid arthritispathogenesiscanadian studiesallergysclerodermainflammatory diseasesclinical rheumatologyneurologyrheumatologytreatment and preventioninflammatory rheumatic diseaseclinical researchsystemic sclerodermac-reactive protein

Best Practices in Scleroderma: An Analysis of Practice Variability in Ssc Centres Within the Canadian Scleroderma Research Group (Csrg).. PubMed (2012)

practice variabilitydiagnosisdermatologydermatological treatmentsclerodermassc centresmedicinesystemic sclerodermabest practices

Thu0249 C - Reactive Protein (Crp) is Associated With High Disease Activity in Ssc and Ild. Results From the Canadian Scleroderma Research Group (Csrg). Annals of the Rheumatic Diseases (2012)

inflammationpathologyrheumatologyclinical immunologyimmunologyrheumatisminflammatory markersreactive proteinsclerodermaimmune dysregulationimmune responsesthu0249 csystemic sclerodermahigh disease activityclinical rheumatology

Associations With Digital Ulcers in a Large Cohort of Systemic Sclerosis: Results From the Canadian Scleroderma Research Group Registry. Arthritis Care & Research (2010)

Sarit KhimdasSarah HardingAsh BonnerBrittany ZummerMurray BaronJanet Pope

public healthepidemiologypathologyarthritisrheumatologysystemic sclerosisdigital ulcersinflammatory rheumatic diseasecanadian studiessclerodermadisease mappinglarge cohortclinical researchsystemic sclerodermaclinical rheumatology

Cyclofenil for Raynaud's Phenomenon in Progressive Systemic Sclerosis. Cochrane Database of Systematic Reviews (1998)

progressive systemic sclerosisarthritisrheumatologyclinical rheumatologyneurological disordersrheumatismvasculitisneuropathologymedicineautoimmune diseasessystemic sclerodermarheumatoid arthritis

1
2
10 / page

Sarah Harding

Assistant Professor of Pediatrics

Upstate Medical University

Sarah Harding is currently serving as a Center For Development, Behavior And Genetics Assistant Professor of Pediatrics at Upstate Medical University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Sarah Harding

Upstate Medical University

Assistant Professor of Pediatrics

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Phosphodiesterase 5 Inhibitors (Pde5I) for the Treatment of Raynaud's Phenomenon. Cochrane Database of Systematic Reviews (2023)

phosphodiesterase 5rheumatologysclerodermamedicinepharmacology

Drug Interventions Versus Placebo for the Treatment of Raynaud’s Phenomenon: Generic Protocol. Cochrane Database of Systematic Reviews (2021)

drug interventionsgeneric protocolskin pharmacologyrheumatologydermatological treatmentmedicinepharmacologyclinical therapeuticspharmacotherapyclinical trials

Calcium Channel Blockers for Primary and Secondary Raynaud's Phenomenon. Cochrane Database of Systematic Reviews (2017)

circulatory physiologysecondary raynaudphysiologyblood vesselselectrophysiologycellular physiologyvascular pharmacologyneurophysiology

calcium channel blockersphysiologyelectrophysiologyneuromuscular medicinephenomenon including lowhiger dosesmedicinepharmacology

Agreement With Guidelines From a Large Database for Management of Systemic Sclerosis: Results From the Canadian Scleroderma Research Group. The Journal of Rheumatology (2012)

Association of C‐Reactive Protein With High Disease Activity in Systemic Sclerosis: Results From the Canadian Scleroderma Research Group. Arthritis Care & Research (2012)

Chayawee MuangchanSarah HardingSarit KhimdasAshley BonnerMurray BaronJanet Pope

Best Practices in Scleroderma: An Analysis of Practice Variability in Ssc Centres Within the Canadian Scleroderma Research Group (Csrg).. PubMed (2012)

practice variabilitydiagnosisdermatologydermatological treatmentsclerodermassc centresmedicinesystemic sclerodermabest practices

Thu0249 C - Reactive Protein (Crp) is Associated With High Disease Activity in Ssc and Ild. Results From the Canadian Scleroderma Research Group (Csrg). Annals of the Rheumatic Diseases (2012)

Associations With Digital Ulcers in a Large Cohort of Systemic Sclerosis: Results From the Canadian Scleroderma Research Group Registry. Arthritis Care & Research (2010)

Sarit KhimdasSarah HardingAsh BonnerBrittany ZummerMurray BaronJanet Pope

Cyclofenil for Raynaud's Phenomenon in Progressive Systemic Sclerosis. Cochrane Database of Systematic Reviews (1998)

progressive systemic sclerosisarthritisrheumatologyclinical rheumatologyneurological disordersrheumatismvasculitisneuropathologymedicineautoimmune diseasessystemic sclerodermarheumatoid arthritis

1
2
10 / page